Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1683755
Max Phase: Preclinical
Molecular Formula: C28H33N9O7
Molecular Weight: 607.63
Molecule Type: Small molecule
Associated Items:
ID: ALA1683755
Max Phase: Preclinical
Molecular Formula: C28H33N9O7
Molecular Weight: 607.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1c(C)c2c(c(O)c1C/C=C(\C)CNCc1cn(C[C@@H]3O[C@H](n4cnc5c(N)ncnc54)[C@@H](O)[C@H]3O)nn1)C(=O)OC2
Standard InChI: InChI=1S/C28H33N9O7/c1-13(4-5-16-21(38)19-17(10-43-28(19)41)14(2)24(16)42-3)6-30-7-15-8-36(35-34-15)9-18-22(39)23(40)27(44-18)37-12-33-20-25(29)31-11-32-26(20)37/h4,8,11-12,18,22-23,27,30,38-40H,5-7,9-10H2,1-3H3,(H2,29,31,32)/b13-4+/t18-,22-,23-,27-/m0/s1
Standard InChI Key: SNFQZPUVORYYMX-ZHDVMFHKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 607.63 | Molecular Weight (Monoisotopic): 607.2503 | AlogP: 0.29 | #Rotatable Bonds: 10 |
Polar Surface Area: 217.81 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.76 | CX Basic pKa: 7.34 | CX LogP: 1.28 | CX LogD: 1.01 |
Aromatic Rings: 4 | Heavy Atoms: 44 | QED Weighted: 0.12 | Np Likeness Score: 0.77 |
1. Felczak K, Chen L, Wilson D, Williams J, Vince R, Petrelli R, Jayaram HN, Kusumanchi P, Kumar M, Pankiewicz KW.. (2011) Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain., 19 (5): [PMID:21324702] [10.1016/j.bmc.2011.01.042] |
Source(1):